Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | Moderna's Stéphane Bancel plans to double down on vaccine production, new variants as mRNA rules in pandemic fight |
|
| 2 | Moderna just laid out its strategy to fight coronavirus variants and says a new shot is ready to be tested |
|
| 3 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $1.9 million of Shares |
|
| 4 | Did Moderna CEO Stéphane Bancel Get Vaccinated? |
|
| 5 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $3.3 million of Shares |
|
| 6 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $2 million of Shares |
|
| 7 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $3.1 million of Shares |
|
| 8 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $1.8 million of Shares |
|
| 9 | Moderna, Pfizer test vaccine strategies against new variants |
|
| 10 | 2 Healthcare Stocks That Could Soar in 2021 |
|
| 11 | EU leaders seek to inject energy into slow vaccine rollout |
|
| 12 | Under fire in EU, AstraZeneca CEO says "hopefully" will meet vaccine supply goals |
|
| 13 | News briefs | News |
|
| 14 | Moderna submits COVID-19 booster shot for variant from South Africa |
|
| 15 | Moderna Announces Investment To Increase Global Manufacturing Capacity For COVID-19 Vaccine |
|
| 16 | Canada Purchases Additional 4 Million Doses of Moderna's COVID-19 Vaccine |
|
| 17 | Fauci: Vaccines for kids could be authorized by September |
|
| 18 | CNBC Transcript: Moderna CEO Stephane Bancel Speaks with CNBC’s “Squawk Box” Today |
|
| 19 | UPDATE 2-S.Korea in talks with Moderna over $200 mln investment to build vaccine factory |
|
| 20 | Coronavirus digest: J&J vaccine prevents COVID – US regulator |
|
| 21 | First on CNBC: CNBC Transcript: Moderna CEO Stephane Bancel Speaks with CNBC’s “Squawk Box” Today |
|
| 22 | Why it's hard to make vaccines and boost supplies |
|
| 23 | Stéphane Bancel’s audacity pays off for Moderna |
|
| 24 | COVID-19 vaccine honchos sold $496 million in stocks last year: report |
|
| 25 | Moderna CEO Stephane Bancel on executive stock sales |
|
| 26 | Moderna CEO Stéphane Bancel outlines a prospective motherlode of Covid-19 vaccine revenue — will a backlash follow? |
|
| 27 | Moderna Chief Sells More Shares Ahead of Key Vaccine Filing |
|
| 28 | Doctors warn that Covid will become endemic and people need to learn to live with it |
|
| 29 | FAQ: Will children be able to get the coronavirus vaccines? |
|
| 30 | Consider the power of light to beat back the darkness of COVID-19 |
|
| 31 | World surpasses 100M confirmed COVID-19 cases |
|
| 32 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $1.3 million of Shares |
|
| 33 | 'The biggest inflection point ever': On R&D day, Moderna CEO Stéphane Bancel doubles down on vaccines and lays out a vision for a '40, 50'-drug biotech |
|
| 34 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $828,671 of Shares |
|
| 35 | Stéphane Bancel, CEO of Moderna, the biotech making a COVID-19 vaccine |
|
| 36 | Daily COVID Tracker: Nigeria to get vaccine in March and UNDP donates kits to ECOWAS |
|
| 37 | Pfizer's vaccine found to be 94% effective in new study – latest updates |
|
| 38 | Moderna CEO: Company expects to know in November whether COVID-19 vaccine works |
|
| 39 | Moderna CEO cheers coronavirus vaccine safety as 'gamechanger,' with 20M doses available by end of year |
|
| 40 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $1.2 million of Shares |
|
| 41 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $604,902 of Shares |
|
| 42 | Moderna CEO reportedly expects coronavirus vaccine interim results in November |
|
| 43 | Moderna CEO says the world will have to live with Covid 'forever' |
|
| 44 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $1.4 million of Shares |
|
| 45 | Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at 39th Annual JPMorgan Virtual Healthcare Conference Transcript |
|
| 46 | Additional Four million doses of Moderna COVID-19 Vaccine purchased by Canada |
|
| 47 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $755,105 of Shares |
|
| 48 | Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at NASDAQ 43rd Virtual Investor Conference (Transcript) |
|
| 49 | Dec 01, 2020 |
|
| 50 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $3.6 million of Shares |
|
| 51 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $2.6 million of Shares |
|
| 52 | Moderna CEO says vaccine likely to protect for 'couple of years' |
|
| 53 | Moderna CEO: Covid-19 Vaccine's 'Fantastic' Results Mean It Could Be Ready Next Month |
|
| 54 | Moderna doesn't expect Covid vaccine data for young children until 2022, CEO says |
|
| 55 | Leadership Live With David Rubenstein: Moderna CEO Stephane Bancel |
|
| 56 | We need a long-haul stimulus that will last as long as the pandemic does |
|
| 57 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $1.5 million of Shares |
|
| 58 | Moderna CEO Hopes to Get Vaccine Approval in Next Few Weeks |
|
| 59 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $892,800 of Shares |
|
| 60 | Indigo Ag Announces an Additional $360M in Financing, Appoints Stéphane Bancel, Moderna CEO, to Board of Directors |
|
| 61 | Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at Piper Sandler 32nd Annual Virtual Healthcare Conference (Transcript) |
|
| 62 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $789,789 of Shares |
|
| 63 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $780,289 of Shares |
|
| 64 | Moderna Inc (MRNA) CEO Stephane Bancel Sold $2.3 million of Shares |
|
| 65 | Coronavirus latest: France targets a fifth of country for stricter anti-Covid measures |
|
| 66 | Moderna's COVID-19 vaccine to cost between $25 and $37: CEO Stephane Bancel |
|
| 67 | Moderna CEO: Vaccines aren't a 'silver bullet,' people must wear masks |
|
| 68 | Covid-19 roundup: Stéphane Bancel sees December EUA for Moderna at earliest; Trump trashes Fauci as 'disaster' and 'idiot' |
|
| 69 | Inside Moderna: The Covid Vaccine Front-Runner With No Track Record and an Unsparing CEO |
|
| 70 | Politics, Science and the Remarkable Race for a Coronavirus Vaccine |
|
| 71 | Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at Jefferies 2020 Virtual London Healthcare Conference (Transcript) |
|
| 72 | Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript) |
|
| 73 | Moderna CEO says its coronavirus vaccine won't be ready until spring of next year |
|
| 74 | Moderna CEO Stéphane Bancel outlines a short path for emergency use of a coronavirus vaccine |
|
| 75 | Moderna Billionaires Gain $410 Million on Vaccine Promise |
|
| 76 | Moderna on Track to Make 100 Million Vaccine Doses by End of March, CEO Says |
|
| 77 | Moderna CEO says coronavirus vaccine won't be ready for FDA till late November: FT |
|
| 78 | Moderna, Inc. (MRNA) CEO Stéphane Bancel at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript) |
|
| 79 | Moderna CEO sees 'high probability' of success with Covid-19 vaccine |
|
| 80 | Why Are Moderna Executives Selling Stock While Developing A Coronavirus Vaccine? |
|
| 81 | New vaccine billionaires gain wealth as Moderna and BioNTech shares soar |
|
| 82 | What are Moderna’s coronavirus vaccine side effects? |
|
| 83 | LONDON BRIEFING: BAE Catches Up On Dividend Payments As Sales Rise |
|
| 84 | Moderna CEO says supply of coronavirus vaccine will be limited, US will help decide who gets it first |
|
| 85 | Astra Data, NovaVax Delay Spur Moderna Vaccine Demand: CEO |
|
| 86 | Moderna to request emergency authorization of coronavirus vaccine |
|
| 87 | The Untold Story of Moderna's Race for a COVID-19 Vaccine |
|
| 88 | Moderna has started turning out COVID-19 vaccine doses for quick shipment if approved: CEO |
|
| 89 | Covid-19 roundup: Moderna CEO Stéphane Bancel becomes a billionaire; Novartis, Incyte pitch Jakafi PhIII to tackle severe cases |
|
| 90 | Moderna CEO Stephane Bancel says coronavirus vaccine price will be low |
|
| 91 | Not All Moderna’s Ready Vaccine Kept for U.S., CEO Says |
|
| 92 | Moderna CEO: I am aligned with shareholders even though I am selling stock |
|
| 93 | Pioneering mRNA CEO Stéphane Bancel bags an eye-popping $58M compensation deal in wake of record IPO |
|
| 94 | Moderna will begin vaccinating Americans hours after FDA green light |
|
| 95 | Riding high after its IPO, Moderna chief nabs $59M, biopharma's biggest 2018 paycheck |
|
| 96 | A coronavirus vaccine rooted in a government partnership is fueling financial rewards for company executives |
|
| 97 | Moderna Vaccine Produces Antibodies in Trial of Older People |
|
| 98 | Moderna soars after getting $483 million in federal funding for coronavirus vaccine development |
|
| 99 | Moderna poaches Amgen vet as CCO, jump-starting commercial team as it rolls out COVID-19 vaccine |
|
| 100 | Moderna CEO and other execs made millions on vaccine announcement |
|